212 related articles for article (PubMed ID: 37966571)
1. Clinical trials on curcumin in relation to its bioavailability and effect on malignant diseases: critical analysis.
Khosravi MA; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3477-3491. PubMed ID: 37966571
[TBL] [Abstract][Full Text] [Related]
2. Is curcumin bioavailability a problem in humans: lessons from clinical trials.
Kunnumakkara AB; Harsha C; Banik K; Vikkurthi R; Sailo BL; Bordoloi D; Gupta SC; Aggarwal BB
Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):705-733. PubMed ID: 31361978
[No Abstract] [Full Text] [Related]
3. [Curcumine (Turmeric - Curcuma longa) as a Supportive Phytotherapeutic Treatment in Oncology].
Frassová Z; Rudá-Kučerová J
Klin Onkol; 2017; 31(1):15-23. PubMed ID: 29488773
[TBL] [Abstract][Full Text] [Related]
4. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment.
Basnet P; Skalko-Basnet N
Molecules; 2011 Jun; 16(6):4567-98. PubMed ID: 21642934
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.
Jurenka JS
Altern Med Rev; 2009 Jun; 14(2):141-53. PubMed ID: 19594223
[TBL] [Abstract][Full Text] [Related]
6. Review: bioavailability and efficacy of 'free' curcuminoids from curcumagalactomannoside (CGM) curcumin formulation.
Matthewman C; Krishnakumar IM; Swick AG
Nutr Res Rev; 2024 Jun; 37(1):14-31. PubMed ID: 36655498
[TBL] [Abstract][Full Text] [Related]
7. Beyond Yellow Curry: Assessing Commercial Curcumin Absorption Technologies.
Douglass BJ; Clouatre DL
J Am Coll Nutr; 2015; 34(4):347-58. PubMed ID: 25856323
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. The golden spice curcumin in cancer: A perspective on finalized clinical trials during the last 10 years.
Karaboga Arslan AK; Uzunhisarcıklı E; Yerer MB; Bishayee A
J Cancer Res Ther; 2022; 18(1):19-26. PubMed ID: 35381757
[TBL] [Abstract][Full Text] [Related]
10. Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers.
Gota VS; Maru GB; Soni TG; Gandhi TR; Kochar N; Agarwal MG
J Agric Food Chem; 2010 Feb; 58(4):2095-9. PubMed ID: 20092313
[TBL] [Abstract][Full Text] [Related]
11. Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies.
Allegra A; Innao V; Russo S; Gerace D; Alonci A; Musolino C
Cancer Invest; 2017 Jan; 35(1):1-22. PubMed ID: 27996308
[TBL] [Abstract][Full Text] [Related]
12. Curcumin: a boon to colonic diseases.
Sareen R; Jain N; Pandit V
Curr Drug Targets; 2013 Sep; 14(10):1210-8. PubMed ID: 23768171
[TBL] [Abstract][Full Text] [Related]
13. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials.
Shehzad A; Wahid F; Lee YS
Arch Pharm (Weinheim); 2010 Sep; 343(9):489-99. PubMed ID: 20726007
[TBL] [Abstract][Full Text] [Related]
14. Conundrum and therapeutic potential of curcumin in drug delivery.
Kumar A; Ahuja A; Ali J; Baboota S
Crit Rev Ther Drug Carrier Syst; 2010; 27(4):279-312. PubMed ID: 20932240
[TBL] [Abstract][Full Text] [Related]
15. Comparative bioavailability of curcuminoids from a water-dispersible high curcuminoid turmeric extract against a generic turmeric extract: a randomized, cross-over, comparative, pharmacokinetic study.
Thanawala S; Shah R; Alluri KV; Somepalli V; Vaze S; Upadhyay V
J Pharm Pharmacol; 2021 Apr; 73(6):816-823. PubMed ID: 33755149
[TBL] [Abstract][Full Text] [Related]
16. An update on Curcuma as a functional food in the control of cancer and inflammation.
Schaffer M; Schaffer PM; Bar-Sela G
Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):605-11. PubMed ID: 26418821
[TBL] [Abstract][Full Text] [Related]
17. Curcumin, the active substance of turmeric: its effects on health and ways to improve its bioavailability.
Abd El-Hack ME; El-Saadony MT; Swelum AA; Arif M; Abo Ghanima MM; Shukry M; Noreldin A; Taha AE; El-Tarabily KA
J Sci Food Agric; 2021 Nov; 101(14):5747-5762. PubMed ID: 34143894
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of curcumin in digestive diseases.
Dulbecco P; Savarino V
World J Gastroenterol; 2013 Dec; 19(48):9256-70. PubMed ID: 24409053
[TBL] [Abstract][Full Text] [Related]
19. Recent progress on curcumin-based therapeutics: a patent review (2012-2016). Part I: Curcumin.
Di Martino RM; Luppi B; Bisi A; Gobbi S; Rampa A; Abruzzo A; Belluti F
Expert Opin Ther Pat; 2017 May; 27(5):579-590. PubMed ID: 28024125
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential.
Fu YS; Chen TH; Weng L; Huang L; Lai D; Weng CF
Biomed Pharmacother; 2021 Sep; 141():111888. PubMed ID: 34237598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
